Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Penfold

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Molecular Microbiology|November 9, 2000
A 76-residue polypeptide of colicin E9 confers receptor specificity and inhibits the growth of vitamin B12-dependent Escherichia coli 113/3 cellsC N Penfold, C Garinot-Schneider, A M Hemmings, et al.
The British Journal of Oral & Maxillofacial Surgery|April 16, 2003
Microvascular free tissue transfer in the management of squamous cell carcinoma of the tongue during pregnancyC J Lloyd, M D Paley, C N Penfold, et al.
Journal of Bacteriology|April 15, 2008
Investigating early events in receptor binding and translocation of colicin E9 using synchronized cell killing and proteolytic cleavageYing Zhang, Mireille N Vankemmelbeke, Lisa E Holland, et al.
Journal of Medical Imaging and Radiation Oncology|April 4, 2020
Comparative proton versus photon treatment planning for the Medicare Medical Treatment Overseas Program: The Royal Adelaide Hospital experienceYvonne Hu, Raymond Dalfsen, Scott N Penfold, et al.
FEMS Microbiology Letters|June 1, 1996
Isolation, characterisation and expression of the bacterioferritin gene of Rhodobacter capsulatusC N Penfold, P L Ringeling, S L Davy, et al.
Biochemistry|August 24, 2005
Clusters in an intrinsically disordered protein create a protein-binding site: the TolB-binding region of colicin E9Kaeko Tozawa, Colin J Macdonald, Christopher N Penfold, et al.
Journal of Medical Radiation Sciences|July 9, 2020
Individualised selection of left-sided breast cancer patients for proton therapy based on cost-effectivenessAnnabelle M Austin, Michael J J Douglass, Giang T Nguyen, et al.
Journal of Bacteriology|July 3, 2004
Flexibility in the receptor-binding domain of the enzymatic colicin E9 is required for toxicity against Escherichia coli cellsChristopher N Penfold, Bryan Healy, Nicholas G Housden, et al.
Journal of Medical Microbiology|January 14, 2026
Clinical isolates from chronic wounds reveal strain-specific, alkyl-quinolone-independent competition in <i>Pseudomonas aeruginosa</i>-<i>Staphylococcus aureus</i> biofilmsBethan Roberts, Ana C da Silva, Tim Sloan, et al.
Journal of Medical Imaging and Radiation Oncology|February 1, 2023
Proton-to-photon comparative treatment planning guidelines for the Australian contextScott N Penfold, Mikaela Dell'Oro, Peter Gorayski, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Molecular Microbiology|November 9, 2000
A 76-residue polypeptide of colicin E9 confers receptor specificity and inhibits the growth of vitamin B12-dependent Escherichia coli 113/3 cellsC N Penfold, C Garinot-Schneider, A M Hemmings, et al.
The British Journal of Oral & Maxillofacial Surgery|April 16, 2003
Microvascular free tissue transfer in the management of squamous cell carcinoma of the tongue during pregnancyC J Lloyd, M D Paley, C N Penfold, et al.
Journal of Bacteriology|April 15, 2008
Investigating early events in receptor binding and translocation of colicin E9 using synchronized cell killing and proteolytic cleavageYing Zhang, Mireille N Vankemmelbeke, Lisa E Holland, et al.
Journal of Medical Imaging and Radiation Oncology|April 4, 2020
Comparative proton versus photon treatment planning for the Medicare Medical Treatment Overseas Program: The Royal Adelaide Hospital experienceYvonne Hu, Raymond Dalfsen, Scott N Penfold, et al.
FEMS Microbiology Letters|June 1, 1996
Isolation, characterisation and expression of the bacterioferritin gene of Rhodobacter capsulatusC N Penfold, P L Ringeling, S L Davy, et al.
Biochemistry|August 24, 2005
Clusters in an intrinsically disordered protein create a protein-binding site: the TolB-binding region of colicin E9Kaeko Tozawa, Colin J Macdonald, Christopher N Penfold, et al.
Journal of Medical Radiation Sciences|July 9, 2020
Individualised selection of left-sided breast cancer patients for proton therapy based on cost-effectivenessAnnabelle M Austin, Michael J J Douglass, Giang T Nguyen, et al.
Journal of Bacteriology|July 3, 2004
Flexibility in the receptor-binding domain of the enzymatic colicin E9 is required for toxicity against Escherichia coli cellsChristopher N Penfold, Bryan Healy, Nicholas G Housden, et al.
Journal of Medical Microbiology|January 14, 2026
Clinical isolates from chronic wounds reveal strain-specific, alkyl-quinolone-independent competition in <i>Pseudomonas aeruginosa</i>-<i>Staphylococcus aureus</i> biofilmsBethan Roberts, Ana C da Silva, Tim Sloan, et al.
Journal of Medical Imaging and Radiation Oncology|February 1, 2023
Proton-to-photon comparative treatment planning guidelines for the Australian contextScott N Penfold, Mikaela Dell'Oro, Peter Gorayski, et al.
Pageof 7